LAB
Price
$1.35
Change
+$0.03 (+2.27%)
Updated
Oct 9, 04:59 PM (EDT)
Capitalization
504.23M
33 days until earnings call
STIM
Price
$2.94
Change
-$0.03 (-1.01%)
Updated
Oct 9, 04:59 PM (EDT)
Capitalization
196.39M
33 days until earnings call
Interact to see
Advertisement

LAB vs STIM

Header iconLAB vs STIM Comparison
Open Charts LAB vs STIMBanner chart's image
Standard BioTools
Price$1.35
Change+$0.03 (+2.27%)
Volume$3.14K
Capitalization504.23M
Neuronetics
Price$2.94
Change-$0.03 (-1.01%)
Volume$5.64K
Capitalization196.39M
LAB vs STIM Comparison Chart in %
LAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
STIM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LAB vs. STIM commentary
Oct 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LAB is a Hold and STIM is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 10, 2025
Stock price -- (LAB: $1.36 vs. STIM: $2.94)
Brand notoriety: LAB and STIM are both not notable
Both companies represent the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: LAB: 108% vs. STIM: 40%
Market capitalization -- LAB: $504.23M vs. STIM: $196.39M
LAB [@Medical/Nursing Services] is valued at $504.23M. STIM’s [@Medical/Nursing Services] market capitalization is $196.39M. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $233.69B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $5.65B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LAB’s FA Score shows that 0 FA rating(s) are green whileSTIM’s FA Score has 0 green FA rating(s).

  • LAB’s FA Score: 0 green, 5 red.
  • STIM’s FA Score: 0 green, 5 red.
According to our system of comparison, STIM is a better buy in the long-term than LAB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LAB’s TA Score shows that 5 TA indicator(s) are bullish while STIM’s TA Score has 3 bullish TA indicator(s).

  • LAB’s TA Score: 5 bullish, 5 bearish.
  • STIM’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, LAB is a better buy in the short-term than STIM.

Price Growth

LAB (@Medical/Nursing Services) experienced а +6.25% price change this week, while STIM (@Medical/Nursing Services) price change was +10.11% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +3.09%. For the same industry, the average monthly price growth was +4.08%, and the average quarterly price growth was +23.20%.

Reported Earning Dates

LAB is expected to report earnings on Nov 11, 2025.

STIM is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Medical/Nursing Services (+3.09% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LAB($504M) has a higher market cap than STIM($196M). STIM YTD gains are higher at: 84.472 vs. LAB (-22.286). STIM has higher annual earnings (EBITDA): -39.31M vs. LAB (-120.98M). LAB has more cash in the bank: 237M vs. STIM (11.1M). LAB has less debt than STIM: LAB (28.6M) vs STIM (80.7M). LAB has higher revenues than STIM: LAB (172M) vs STIM (111M).
LABSTIMLAB / STIM
Capitalization504M196M257%
EBITDA-120.98M-39.31M308%
Gain YTD-22.28684.472-26%
P/E RatioN/AN/A-
Revenue172M111M155%
Total Cash237M11.1M2,135%
Total Debt28.6M80.7M35%
FUNDAMENTALS RATINGS
LAB vs STIM: Fundamental Ratings
LAB
STIM
OUTLOOK RATING
1..100
669
VALUATION
overvalued / fair valued / undervalued
1..100
34
Fair valued
42
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
96100
PRICE GROWTH RATING
1..100
6043
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5044

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

LAB's Valuation (34) in the Medical Specialties industry is in the same range as STIM (42). This means that LAB’s stock grew similarly to STIM’s over the last 12 months.

LAB's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as STIM (100). This means that LAB’s stock grew similarly to STIM’s over the last 12 months.

LAB's SMR Rating (96) in the Medical Specialties industry is in the same range as STIM (100). This means that LAB’s stock grew similarly to STIM’s over the last 12 months.

STIM's Price Growth Rating (43) in the Medical Specialties industry is in the same range as LAB (60). This means that STIM’s stock grew similarly to LAB’s over the last 12 months.

STIM's P/E Growth Rating (100) in the Medical Specialties industry is in the same range as LAB (100). This means that STIM’s stock grew similarly to LAB’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
LABSTIM
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
72%
MACD
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 24 days ago
81%
Bullish Trend 2 days ago
85%
Declines
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 8 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
LAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
STIM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NBMOX54.73N/A
N/A
Neuberger Berman Small Cap Growth Tr
FRIOX11.92N/A
N/A
Fidelity Advisor Real Estate Income C
HWNIX15.02N/A
N/A
Hotchkis & Wiley International Value I
CSDGX15.60N/A
N/A
Copeland SMID Cap Dividend Growth A
PGTYX91.64-0.11
-0.12%
Putnam Global Technology Y

STIM and

Correlation & Price change

A.I.dvisor indicates that over the last year, STIM has been loosely correlated with BWAY. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if STIM jumps, then BWAY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STIM
1D Price
Change %
STIM100%
+2.06%
BWAY - STIM
34%
Loosely correlated
+1.94%
DCTH - STIM
31%
Poorly correlated
+2.78%
DIZTF - STIM
31%
Poorly correlated
N/A
MASI - STIM
30%
Poorly correlated
+2.31%
LAB - STIM
27%
Poorly correlated
+1.54%
More